Clients
How to Invest in Cannabis Delivery
Delivery services of all kinds experienced record-breaking growth in 2020 thanks to a global pandemic that has depressed retailers, restaurants, and grocery stores. Of course, these trends are just an acceleration of an existing transition from brick-and-mortar to e-commerce—a trend that many in the cannabis industry are betting will be transformative. Let’s take a look […]
HempFusion Expands Global Footprint to Europe Through Ireland
January 14, 2021 07:05 AM Eastern Standard Time DENVER–(BUSINESS WIRE)–HempFusion Wellness Inc. (TSX:CBD.U) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce its entrance into the European market through an exclusive distribution agreement with a European distributor with an extensive retail store […]
VANCOUVER, British Columbia, JANUARY 13, 2021 Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE:CLC) (FRANKFURT: CLB) is pleased to announce that it is beginning to produce ultra-high potency cannabis distillate oils from its 32,500 kg / 71,650 lb harvest of sun-grown cannabis cultivated during the Company’s inaugural growing season, which can […]
CBD Innovator, HempFusion, Makes Successful Debut on TSX
HempFusion Wellness Inc. (TSX: CBD-U) shares soared over 65% following their successful debut on the Toronto Stock Exchange (TSX) on Wednesday, January 6, 2021. Cannabidiol, or CBD, has become one of the most popular health and wellness products in the world over the past couple of years. According to Research and Markets, the global […]
VANCOUVER, British Columbia, Jan. 06, 2021 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. (“Pure” or the “Company”) (CSE: PULL)(XFRA: A2QJAJ) is pleased to announce that, due to strong investor demand, it has increased its non-brokered private placement offering of special warrants (each, a “Special Warrant”) previously announced on December 16, 2020 (the “Private Placement”). Under the upsized […]
HempFusion (TSX:CBD.U): New Listing on the Toronto Stock Exchange
CBD sales are projected to reach $16.8 billion by 2025, according to Brightfield Group, but the market remains extremely fragmented. With a glut of non-differentiated and low-quality products, regulators are poised to introduce new rules governing the market as consumers increasingly seek out the highest quality options that they can trust. Let’s take a look […]
Psychedelic Wellness-Focused Company Delic Corp Announces Shep Gordon to Join Advisory Board
VANCOUVER, BC, Jan. 5, 2021 /CNW/ – Delic Corp. (“DELIC” or the “Company“) (CSE: DELC), a psychedelic wellness-focused company, is pleased to welcome Shep Gordon to the advisory board. Shep Gordon is an American talent manager, Hollywood film agent, and producer. Matt Stang, Founder of DELIC commented, “We are very excited to have Shep on board. His wealth of experience across multiple business’ […]
Cannabis oil during the extraction process at the Company’s facility in the Christina Lake region of British Columbia Close-up of cannabis extract being processed by the Company, demonstrating its viscosity VANCOUVER, British Columbia, Jan. 05, 2021 (GLOBE NEWSWIRE) — Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE:CLC) (FRANKFURT: CLB) is pleased to […]
Christina Lake Cannabis Unlocks Value via Extraction
Many licensed producers have launched value flower brands at competitive prices to grow revenue. While Christina Lake Cannabis Corp. (CSE: CLC) produces some of the industry’s lowest cost cannabis flower, the company intends to leverage its low-cost inputs into high margin extracts to create Cannabis 2.0 products. Let’s take a closer look at the company’s […]
VANCOUVER, British Columbia, Dec. 23, 2020 (GLOBE NEWSWIRE) — Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE:CLC) (FRANKFURT: CLB) is pleased to announce that it has produced its first batch of cannabis-derived crude oil produced using its Vitalis R-200-H-GMP-SS extraction system (“Vitalis System”), which was commissioned earlier this quarter as announced in […]
MagicMed zielt mit dem Programm für pharmazeutische Derivate auf einen massiven Markt ab
Der Markt für Psychedelika ist aufgrund des unentdeckten therapeutischen Potenzials psychedelischer Moleküle schwer zu berechnen. Die wissenschaftliche Gemeinschaft hat gezeigt, dass Psychedelika mehrere Milliarden-Dollar-Märkte im Bereich Gehirn und psychische Gesundheit behandeln können. MagicMed Industries zielt darauf ab, Teile beider Märkte zu erobern, indem es ein einzigartiges, patentgeschütztes Portfolio an geistigem Eigentum entwickelt, das mehrere Medikamentenkandidaten, […]
MagicMed Targets Massive Market with Pharmaceutical Derivatives Program
The psychedelics market is hard to calculate because of the undiscovered therapeutic potential of psychedelic molecules. The scientific community has shown that psychedelics could treat multiple multibillion-dollar markets in the brain and mental health space. MagicMed Industries positions itself to capture portions of each market by developing a unique, patent-protected intellectual property portfolio that safeguards […]
Tryp Debuts on the Canadian Securities Exchange
Tryp Therapeutics Inc. (CSE: TRYP) began trading on the Canadian Securities Exchange (CSE) on December 18, 2020 under the ticker symbol “TRYP”. “Trading on the CSE is a significant milestone in Tryp’s mission to transform the treatment of neuropsychiatric diseases with safe and effective psychedelic medicine,” said CEO James Kuo, MD. “All of the […]
Tryp Therapeutics Appoints Peter Guzzo, PhD, as Vice President, Drug Development
La Jolla, California–(Newsfile Corp. – December 22, 2020) – Tryp Therapeutics Inc. (CSE: TRYP) (“Tryp” or the “Company“) a pharmaceutical company focused on identifying and developing compounds for diseases with high unmet medical needs, announced today it has appointed Dr. Peter Guzzo as its Vice President of Drug Development. Dr. Guzzo has devoted his entire 25-year professional […]
CALGARY, AB, Dec. 22, 2020 /CNW/ – MagicMed Industries Inc. (CSE: MGIC reserved) (“MagicMed” or the “Company“) announced today that it has completed the establishment of the psilocybin-derivatives patent portfolio of the PsybraryTM and the launch of the Candidate Selection program. The PsybraryTM is a proprietary physical and knowledgebase collection of novel psychedelic-derivative drug candidates, manufacturing methods, pharmacological data, and patent […]
Psychedelics Production Challenges & Solutions
Psilocybin and other tryptamine-based compounds could become blockbuster therapeutics for the treatment of depression, post-traumatic stress disorder and other difficult to treat psychiatric conditions. While many clinical trials are underway, researchers are turning their attention toward the problem of mass-producing psychedelics in a cost-effective way. Let’s take a look at some of the production challenges […]
Christina Lake Cannabis Expands Production After Bumper Harvest
The cannabis industry experienced strong growth throughout the COVID-19 pandemic as people spend more time at home. According to Statistics Canada, sales between April and June were 74% higher than the same period a year ago. These trends have continued into the third quarter as Canadians increasingly move away from black market dealers. Christina Lake […]
VANCOUVER, British Columbia, Dec. 18, 2020 (GLOBE NEWSWIRE) — Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE:CLC) (FRANKFURT: CLB) is pleased to announce that after its inaugural growing season in which the Company produced 32,500 kg / 71,650 lb of sun-grown cannabis, more than double its initially announced forecast of 15,000 kg […]
Tryp Therapeutics Begins Trading on the Canadian Securities Exchange
La Jolla, CA – December 18, 2020 – Tryp Therapeutics Inc. (“Tryp” or the “Company”) (CSE: TRYP) is pleased to announce that the Company’s common shares have commenced trading on the Canadian Securities Exchange (“CSE”) under the symbol “TRYP” effective December 18, 2020. James Kuo, MD, CEO states, “Trading on the CSE is a significant milestone in […]
Innovation zahlt sich aus bei Psychedelika
Es besteht ein erhebliches Interesse am psychedelischen Bereich und an den vielversprechenden psychedelischen Molekülen für die Behandlung von psychischen Erkrankungen. Geisteskrankheiten sind eine allgegenwärtige menschliche Erfahrung und eine bisher nur unzureichend behandelte medizinische Notwendigkeit. Psychedelika bieten eine Alternative zu unwirksamen Behandlungen, da sie über andere Wirkmechanismen funktionieren. Psychedelische Arzneimittel müssen jedoch verbessert werden, um aus […]
HempFusion Prepares to Go Public as a Unique Play on CBD
Charlotte’s Web Holdings Inc. (TSX: CWEB) bought Abacus Health Products Inc. in a stock transaction worth about $100 million last June. With competition on the rise in the CBD industry, Abacus provided Charlotte’s Web with a portfolio of over-the-counter (OTC) topical products that combined active pharmaceutical ingredients with hemp extracts. HempFusion Inc. (TSX: CBD.U – […]
Innovation Pays Off in Psychedelics
There has been significant interest in the psychedelic space and of the promise psychedelic molecules show in treating mental health conditions. Mental illness is a ubiquitous human experience and an insufficiently addressed medical necessity. Psychedelics offer an alternative to ineffective treatments by acting via a different mechanism of action. However, psychedelic pharmaceuticals need improvement to […]
Tryp Therapeutics Completes Initial Public Offering
La Jolla, CA – December 17, 2020 – Tryp Therapeutics Inc. (“Tryp” or the “Company“) is pleased to announce the successful closing of previously announced initial public offering (the “Offering“) of units (the “Units”). A total of 20,010,000 Units were sold, including 2,610,000 Units following the exercise in full by the Agent (as defined herein) […]
Red White & Bloom Signs Term Sheet for US $60M Non-Dilutive Credit Facility
December 17, 2020 11:00 ET | Source: Red White & Bloom Brands Inc. Proceeds to be used to acquire THC license and assets in Illinois, repay 12% coupon debt with lower 7% coupon debt, and improve working capital position TORONTO, Dec. 17, 2020 (GLOBE NEWSWIRE) — Red White & Bloom Brands Inc. (CSE: RWB and OTC: RWBYF) (“RWB” or […]
VANCOUVER, British Columbia, Dec. 16, 2020 (GLOBE NEWSWIRE) — Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE:CLC) (FRANKFURT: CLB) is pleased to announce that it has appointed Gil Playford, an internationally accomplished senior corporate executive and entrepreneur in the mining and resource sectors, to its Board of Directors as well as to […]
VANCOUVER, British Columbia, Dec. 16, 2020 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company, is pleased to announce that it has begun to build-out the 4th unit in its facility for the extraction of mushrooms and to commence research and development of psilocybin under […]
Just How Large is the Psychedelics Market?
The psychedelics industry may appear to have suddenly emerged as one of the hottest corners of the stock market, but researchers have been working for decades to show the efficacy of these treatments and regulators are just starting to appreciate the possibilities. Investors could see strong growth in the industry as companies commercialize breakthrough therapeutics […]
Pure Extracts Preparing Application for Dealers Licence
December 10, 2020 00:05 ET | Source: Pure Extracts Technologies Corp. VANCOUVER, British Columbia, Dec. 10, 2020 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushroom sector, is pleased to announce that it has engaged a globally recognized […]
December 09, 2020 00:05 ET | Source: Pure Extracts Technologies Corp. VANCOUVER, British Columbia, Dec. 09, 2020 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), is a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushroom sector. The Company is pleased to announce that it has signed […]
How to Position Your Cannabis Portfolio for a Biden Presidency
The House of Representatives cast a historic vote to end the nationwide prohibition on cannabis on December 4, 2020. While the MORE Act would remove cannabis from the Controlled Substances Act and decriminalize the drug across the country, the legislation will almost certainly fail to pass the Republican-controlled Senate. While decriminalization won’t happen this year, […]
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer